Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Mus musculus | Jul 23, 2024 | ||||||
GSE116565 |
Signalling pathways drive heterogeneity of ground state pluripotency
|
40 | Kirsten R McEwen | Jul 23, 2024 | ||||
GSE160519 |
Vascular and perivascular cell profiling reveals the molecular and cellular bases of blood-brain barrier heterogeneity [scRNA-Seq]
|
52 | Sarah Pfau | Jul 23, 2024 | ||||
GSE173293 |
Single-cell RNA sequencing reveals a role of Phf2 in promoting the exit of postnatal neural stem cell from shallow quiescence.
|
2 | Oleg Grinchuk | Jul 23, 2024 | ||||
GSE180827 |
AOS10-FMT could rescure the adverse effects induced by STZ on the kidney
|
18 | Yong Zhao | Jul 23, 2024 | ||||
GSE189812 |
Engineered T cell therapy for central nervous system injury [control tissues TCR scRNA-seq]
|
8 | Jonathan Kipnis | Jul 23, 2024 | ||||
GSE216388 |
Engineered T cell therapy for central nervous system injury [FACS-Tcells]
|
192 | Jonathan Kipnis | Jul 23, 2024 | ||||
GSE216389 |
Engineered T cell therapy for central nervous system injury [CD45+ scRNA-seq]
|
2 | Jonathan Kipnis | Jul 23, 2024 | ||||
GSE216390 |
Engineered T cell therapy for central nervous system injury [spinal cord TCR scRNA-seq]
|
4 | Jonathan Kipnis | Jul 23, 2024 | ||||
GSE216391 |
Engineered T cell therapy for central nervous system injury
|
|
230 | Jonathan Kipnis | Jul 23, 2024 | |||
GSE222941 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration [RNA-seq: wildtype_EMCN]
|
11 | Kim Theilgaard-Mönch | Jul 23, 2024 | ||||
GSE222942 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration [RNA-seq: EMCN_KO]
|
7 | Kim Theilgaard-Mönch | Jul 23, 2024 | ||||
GSE222943 |
Endomucin marks quiescent long-term multi-lineage repopulating hematopoietic stem cells and is essential for their transendothelial migration
|
18 | Kim Theilgaard-Mönch | Jul 23, 2024 | ||||
GSE233095 |
STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia [RNASEQ_AML_CPGDOX]
|
12 | Haiqing Li | Jul 23, 2024 | ||||
GSE233096 |
STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia [RNASEQ_AML_DECSCR]
|
12 | Haiqing Li | Jul 23, 2024 | ||||
GSE233097 |
STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia [RRBS]
|
12 | Haiqing Li | Jul 23, 2024 | ||||
GSE233098 |
STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia [scRNA-seq]
|
5 | Haiqing Li | Jul 23, 2024 | ||||
GSE233099 |
STAT3 inhibition permits epigenetic reprogramming and TLR9/IRF8-driven differentiation of inv(16) acute myeloid leukemia.
|
41 | Haiqing Li | Jul 23, 2024 | ||||
GSE236506 |
RNA sequencing analysis of bladder tissue from CFT073-infected C57B/6J mice with or without treatments of D-xyl@epsilonPLCDs and epsilonPLCDs
|
3 | Chunhui Miao | Jul 23, 2024 | ||||
GSE241199 |
Vascular and perivascular cell profiling reveals the molecular and cellular bases of blood-brain barrier heterogeneity [GEOMx]
|
53 | Sarah Pfau | Jul 23, 2024 | ||||
GSE241206 |
Vascular and perivascular cell profiling reveals the molecular and cellular bases of blood-brain barrier heterogeneity
|
105 | Sarah Pfau | Jul 23, 2024 |